Sepsis, meningitis and cerebral abscesses caused by Citrobacter koseri by Marecos, C et al.
BMJ Case Reports 2012; doi:10.1136/bcr.10.2011.4941 1 of 5
 BACKGROUND 
 Newborns have the highest incidence of bacterial menin-
gitis, with this infection being more common in the ﬁ rst 
month of life than at any other time. The global incidence 
is 0.25, with one case per 1000 live births and 0.15 cases 
per 1000 full term births. 1 
 Around 30% of newborns with sepsis have associ-
ated meningitis. The most common pathogens are group 
B  Streptococcus , enteric bacilli and  Listeria monocytogenes . 
Neonatal meningitis due to  Citrobacter koseri is very rare. 
Although the source of neonatal infection cannot be iden-
tiﬁ ed in the majority of cases, vertical transmission dur-
ing delivery may occur as well as nosocomial transmission 
from healthcare workers. 
 Citrobacter species are Gram-negative enteric bacilli 
found in the intestinal tract of humans and animals, and 
are also present in soil and water. The genus consists of 
three different species, one of which,  C koseri , is a par-
ticularly devastating, although rare, cause of meningitis. 2 
Meningitis due to this agent leads to intracerebral abscesses 
in most cases (75%), with other complications including 
cerebral oedema, diffuse necrotising meningoencephali-
tis, ventriculitis, cerebritis, empyema, pneumatocephalus, 
cerebral infarction hydrocephalus and severe neurologi-
cal impairment (50% of cases). 3 Seizures occur in 75% of 
cases. 3 
 The death rate is high (30%), with the surviving infants 
having severe neurological sequelae, the most frequent 
(80%) being mental retardation. 4 
 CASE PRESENTATION 
 We report the case of a female newborn, the ﬁ rst twin of 
non-consanguineous healthy parents, who was born after 
a diamniotic dichorionic 36-week gestation with adequate 
prenatal care. Maternal vaginal screening for group B 
 Streptococcus was positive at 35 weeks. 
 Prenatal ultrasound revealed asymmetric fetal growth 
since the 26th week of gestation, showing growth restric-
tion of the ﬁ rst twin (10th percentile) with the second twin 
at the 50th percentile. The twins were delivered by elec-
tive caesarean section due to growth restriction and altered 
diastolic ﬂ ow in the umbilical artery. 
 The Apgar score of the smaller infant was 9/10, birth 
weight was 2140 g (3rd–10th percentile), length was 41 
cm (<3rd percentile) and head circumference 31.5 cm (10th 
percentile). 
 The newborn was admitted to the neonatal intensive 
care unit for exclusive parenteral feeding (nothing by 
mouth for 48 h) due to diastolic ﬂ ux alterations. On admis-
sion, the patient had a normal physical exam and labora-
tory evaluation. An umbilical venous catheter was placed. 
 On day 3 (51 h of age), the patient experienced tachy-
cardia (220 ppm) and temperature instability (37.5°C) with 
a rise in inﬂ ammatory markers (C reactive protein 1.89 
mg/dl). An electrocardiogram showed sinus tachycardia. 
Penicillin and gentamicin were started. 
 Septic shock with disseminated intravascular coagula-
tion occurred 6 h later and required ventilatory, inotropic 
and transfusional support. Vancomycin and meropenem 
were started and penicillin suspended. 
 On day 4, generalised tonic convulsions occurred. 
Electroencephalogram (EEG) showed severe encephalic dys-
function with global ﬂ attened electrogenesis and multifocal 
ictal and interictal paroxysmal activity at temporal regions 
bilaterally. Phenobarbital was started. A transfontanellar 
ultrasound (TFU) revealed no alterations on this date. 
 On day 6,  C koseri was isolated from the blood culture 
taken on day 3.  C koseri was sensitive to amoxicillin plus 
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clavulanic acid, cefradine, cefotaxime, cefuroxime, gen-
tamicin, tobramycin, ciproﬂ oxacin, cotrimoxazole, tazo-
bac and meropenem, and resistant to ampicillin. In light 
of antibiotic susceptibility, vancomycin was stopped, and 
therapy maintained with gentamicin and meropenem. On 
the same day, TFU showed an isolated temporal abscess, 
with follow-up TFU showing multiple bilateral abscesses 
more numerous in the right hemisphere ( ﬁ gure 1 ). On day 
9, abdominal ultrasound revealed one hepatic abscess. 
 On day 8, EEG showed a reduction in ictal events and a 
slight improvement in basal activity. Phenytoin was added 
to the drug regimen due to the presence of ictal events on 
EEG although no clinical convulsions were seen. 
 Ventilation, dopamine and morphine were stopped on 
day 12 and on day 15 clinical stability was achieved. A 
lumbar puncture was carried out, and cerebral spinal ﬂ uid 
(CSF) analysis revealed 61 cells (lymphocytes), proteins 
201 mg/dl and glucose 26 mg/dl. CSF culture was nega-
tive. Cefotaxime was added to the previous therapy and 
gentamicin was stopped. 
 TFU and cranioencephalic MR showed multiple cerebral 
abscesses on day 15 ( ﬁ gure 2 ). On day 16, neurosurgical 
evaluation ruled out the possibility of surgery due to the 
multiple lesions and the absence of mass effect. 
 Abdominal ultrasound on day 22 showed a reduction 
in the diameter of the hepatic lesion with resolution on 
day 37. 
 EEG on day 36 revealed well-structured electrogenesis 
with slight multifocal paroxysmal activity more persistent 
on the right temporal channels. 
 A 6-week course of intravenous antibiotic therapy was 
completed. TFU and cranioencephalic MR at the time of 
discharge showed multiloculated cystic encephalomalacia 
and diffuse hygroma ( ﬁ gure 3 ). 
 OUTCOME AND FOLLOW-UP 
 Currently, the patient is 14 months old and presents axial 
hypotonia and decreased number of movements but is 
able to feed herself. She has accomplished all neurodevel-
opmental milestones expected of her age. 
 Ophthalmological and auditory evaluation were normal. 
There were no further clinical convulsions and EEG was 
normal at 5 months of age. She is being weaned off anti-
convulsant therapy. 
 The ﬁ rst twin and the mother were clinically asympto-
matic during the entire period and analytical evaluation 
showed negative infection parameters and negative blood 
culture for the second twin. 
 DISCUSSION 
 C koseri is a very rare cause of neonatal meningitis and 
infection is frequently associated with cerebral abscesses. 
Only a few cases have been reported. 3 – 11 
 The reason why Citrobacter particularly affects neonates 
is not known, nor why it preferentially involves the central 
nervous system (CNS). 3 A speciﬁ c 32-kD outer membrane 
protein may play a role as a neuro-virulent factor, provid-
ing Citrobacter tropism for the CNS and thus causing men-
ingitis and cerebral abscesses. 3 
 Around 76% of newborns with  C koseri meningitis 
develop brain abscesses 2 in contrast to other types of 
Gram-negative meningitis where this occurs in only 10% 
of cases. 3 Globally, meningitis has a death rate of around 
10%, rising to 30% when Citrobacter is the agent. 4 
 In this case, the newborn became symptomatic on day 3 
and  C koseri was isolated from blood culture from the same 
day. The source of infection was not established. Other 
case reports describe symptomatic Citrobacter infection 
occurring from day 1 to day 60 5  7 and both vertical and 
 Figure 1  Transfontanellar ultrasound image showing temporal abscess. 
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nosocomial transmission have been described. 7 There is 
one report of Citrobacter infection in twins: twin one was 
symptomatic and twin two was asymptomatic, but both 
had Citrobacter isolated from CSF culture. 2 
 Vertical transmission could not be established in the case 
described here. The mother was asymptomatic through-
out pregnancy and after delivery, there were no signs of 
vaginal or intestinal infection or chorioamnionitis and the 
amniotic membranes were ruptured intrapartum. From 
the 26th week of gestation, the newborn showed growth 
restriction, which can occur in a twin pregnancy due to 
events other than infection. The second twin had normal 
growth during gestation and showed no adverse clinical 
events in the neonatal period. He was clinically asympto-
matic, and blood analysis and culture were negative. 
 Nosocomial infection was also not proven. A venous 
umbilical catheter was present from day 1 to day 6 and 
no inﬂ ammation of the skin or umbilical cord were seen 
during this time. Culture from the catheter was negative. 
There were no other cases of Citrobacter infection among 
the neonates or the healthcare professionals, although a 
routine search (hands, surfaces and liquids) for this agent 
was not performed. 
 In a newborn diagnosed with Citrobacter infection, a 
lumbar puncture is mandatory due to the need for early 
diagnosis and appropriate treatment in case of cerebral 
abscesses. CSF culture remains the gold standard for the 
diagnosis of meningitis 12 ; other CSF parameters should be 
interpreted with caution due to their high variability. 12 
 In this case, lumbar puncture could only be carried out 
on day 12 due to haemodynamic instability; neverthe-
less, CSF cell count and chemical assays suggested men-
ingitis. This reinforces the need for lumbar puncture in 
every newborn with sepsis, since the symptoms and signs 
of meningitis in newborns are not speciﬁ c. 12 Indeed, CSF 
culture can be negative due to previous antibiotherapy, 
as in our case where the newborn had been exposed to 9 
days of meropenem and gentamicin and a short course of 
vancomycin. 
 According to Gaschignard  et al , neonatal meningitis has 
a death rate of 13% and up to 25% in preterm or small for 
gestational age infants, regardless of aetiology. 13 Tatishvili 
 et al described the outcome of bacterial meningitis accord-
ing to the time of disease onset (before 72 h of life), mater-
nal chronic infection and brain injury in newborns. 14 These 
characteristics were predictors of severe complications 
in neonatal bacterial meningitis, such as brain abscess, 
ventriculitis, neonatal seizures, coma and neutropenia, 
and ultimately predictors of severe neurodevelopmen-
tal outcome. 14 Gram-negative bacillary meningitis was 
also associated with worst prognosis 15 as well as seizures 
for >72 h, presence of coma, use of inotropic agents and 
leucopenia. 16 
 After meningitis is diagnosed, antibiotics should be 
selected according to CNS penetration and the spectrum 
of action. Traditionally, a combination of third genera-
tion cephalosporins and aminoglycosides is chosen, 3  5 – 7 
although aminoglycoside resistance has been reported. 17 
In such cases, amikacin is superior to gentamicin. 6 
 Ciproﬂ oxacin and meropenem may be valuable options 
due to their CNS penetration. 3 Cloranfenicol, cotrimoxazol 
and imipenem-cilastatina are also valid choices, 8 although 
cloranfenicol and ciproﬂ ocaxin are not usually used in 
newborns. 
 The length of antibiotherapy should be extended in 
Citrobacter meningitis to at least 21 days 7 and 4–6 weeks 
if abscesses are present. 5  7 
 In the present case, after conﬁ rmation of cerebral 
abscesses on cranioencephalic MR (day 15), therapy was 
adjusted according to Citrobacter antibiotic susceptibility. 
The authors believe this could have been accomplished 
earlier as soon as the abscesses were seen on TFU (day 6), 
as earlier use of antibiotics with cerebral penetrance guar-
antees a better outcome. 
 Figure 2  Cranioencephalic MR image showing multiple cerebral 
abscesses. 
 Figure 3  Cranioencephalic MR image showing multiloculated 
cystic encephalomalacia. 
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 Urgent neurosurgical evaluation is required after a diag-
nosis of cerebral abscesses. Accessible cerebral abscesses 
and ventriculites with hydrocephalus should be drained. 
Surgical drainage should also be considered when there 
is no response to antibiotics. In the literature, the neuro-
surgical approach is associated with a better prognosis, 
especially when obstruction is present. 5 Cerebritis and 
infarctation have no surgical indication. 5 In this case, suc-
cessful surgery was not feasible due to the high number of 
lesions and absence of mass effect. 
 Although no clinical convulsions were seen, phenytoin 
was added because of the abscesses and the persistent alter-
ations on EEG despite maximum doses of phenobarbital. 
 In the case described, the neonate was a late preterm 
infant with growth restriction and altered diastolic ﬂ ow 
in the umbilical artery. In light of the risk of necrotising 
enterocolitis (NEC), an umbilical catheter was placed and 
parenteral feeding started. 
 Our understanding of the pathogenesis of NEC remains 
incomplete, 18 but it seems to be multifactorial and to 
involve an over-reaction of the immune system to an 
unspeciﬁ c insult. 19 The risk is inversely proportional to ges-
tational age and birth weight, 18 and fetal growth restriction 
and compromise may be additional speciﬁ c risk factors. 18 
Careful feeding advancement may be an evidence-based 
strategy to decrease the incidence of NEC. 19 However, 
delayed enteral feeding, the clinical importance of which is 
unclear, could harm functional adaptation of the gastroin-
testinal tract and prolong the need for parenteral nutri-
tion with its attendant infectious and metabolic risks. 20 
The authors recognise the risk associated with umbilical 
venous catheter placement and that this procedure could 
have been detrimental to the newborn. 
 Currently, the newborn has axial hypotonia and a 
normal neurosensory evaluation, but neurological out-
come is unpredictable and multi-disciplinary follow-up is 
necessary. 
 Learning points 
 ▶  Citrobacter neonatal infection is rare and should be 
suspected if the clinical evolution is severe. 
 The source of Citrobacter infection may not be evident,  ▶
but vertical transmission and nosocomial infection 
have been reported. 
 The use of an umbilical venous catheter is associated  ▶
with risk of sepsis. 
 Serial neuroimaging is mandatory in order to identify  ▶
early cerebral complications. 
 Third generation cephalosporins and aminoglycosides  ▶
were used; surgical drainage should always be 
considered. 
 Medical follow-up after discharge should be  ▶
implemented to detect and treat sequelae. 
 Competing interests  None. 
 Patient consent  Obtained. 
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